Y. Horsmans

N. Lanthier, I. Leclercq, Patrice D Cani, 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Clodronate liposomes: All sites of injection are not equal

N. Lanthier, I. Leclercq, Y. Horsmans, 2010, Hepatology.

Detection and segmental location of malignant hepatic tumors: comparison of ferumoxides-enhanced gradient-echo and T2-weighted spin-echo MR imaging.

B. V. Van Beers, C. Grandin, R. Demeure, 1997, AJR. American journal of roentgenology.

Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases?

C. Sempoux, J. Machiels, J. Canon, 2007, Liver international : official journal of the International Association for the Study of the Liver.

Prevalence and clinical relevance of pathological hepatic changes occurring after neoadjuvant chemotherapy for colorectal liver metastases.

C. Sempoux, J. Machiels, Y. Humblet, 2010, Surgery.

Kupffer cell activation is a causal factor for hepatic insulin resistance.

N. Lanthier, I. Leclercq, Patrice D Cani, 2010, American journal of physiology. Gastrointestinal and liver physiology.

Adult-to-adult living related liver transplantation: initial experience.

O. Ciccarelli, J. Lerut, Y. Horsmans, 2001, Acta gastro-enterologica Belgica.

The surgical management of congenital liver cysts

C. Sempoux, D. Glineur, P. Gianello, 2001, Surgical Endoscopy.

Inhibition of the Ras oncoprotein reduces proliferation of hepatocytes in vitro and in vivo in rats.

I. Leclercq, A. da Silva Morais, A. Saliez, 2008, Clinical science.

The metabolic syndrome: how it may influence hepatic stellate cell activation and hepatic fibrosis

N. Lanthier, I. Leclercq, Y. Horsmans, 2009, Current opinion in clinical nutrition and metabolic care.

Muscle fat content is strongly associated with NASH: a longitudinal study in patients with morbid obesity.

I. Leclercq, L. V. Van Gaal, L. Vonghia, 2021, Journal of hepatology.

Rationale of adding muscle volume to muscle fat infiltration in the definition of an adverse muscle composition is unclear

I. Leclercq, Y. Horsmans, M. Nachit, 2021, JHEP reports : innovation in hepatology.

Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models

I. Leclercq, C. Bouzin, J. Thissen, 2020, Journal of cachexia, sarcopenia and muscle.

Adult polycystic liver disease: is fenestration the most adequate operation for long-term management?

B. V. Van Beers, F. Que, Y. Horsmans, 1997, Annals of surgery.

Activation of brown adipose tissue enhances the efficacy of caloric restriction for treatment of nonalcoholic steatohepatitis

I. Leclercq, G. Farrell, Y. Horsmans, 2018, Laboratory Investigation.

Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity.

R Materne, J Jamart, A M Smith, 2001, AJR. American journal of roentgenology.

Capillarization of the sinusoids in liver fibrosis: Noninvasive assessment with contrast‐enhanced MRI in the rabbit

C. Sempoux, B. V. Van Beers, Anne M. Smith, 2003, Magnetic resonance in medicine.

Conservative and operative management of benign solid hepatic tumours: a successful stratified algorithm

C. Sempoux, B. V. Van Beers, L. Annet, 2010, European journal of gastroenterology & hepatology.

MR imaging of hypervascular liver tumors: Timing optimization during the arterial phase

B. V. Van Beers, Anne M. Smith, J. Jamart, 1999, Journal of magnetic resonance imaging : JMRI.

Expression and DNA-binding activity of signal transducer and activator of transcription 3 in alcoholic cirrhosis compared to normal liver and primary biliary cirrhosis in humans.

Y. Horsmans, P. Stärkel, A. Strain, 2003, The American journal of pathology.

After portal branch ligation in rat, nuclear factor κB, interleukin‐6, signal transducers and activators of transcription 3, c‐fos, c‐myc, and c‐jun are similarly induced in the ligated and nonligated lobes

C. Sempoux, Y. Horsmans, P. Stärkel, 1999, Hepatology.

Defective adaptive thermogenesis contributes to metabolic syndrome and liver steatosis in obese mice.

C. Detrembleur, I. Leclercq, A. Bol, 2017, Clinical science.

Reduction in hepatic cytochrome P-450 is correlated to the degree of liver fat content in animal models of steatosis in the absence of inflammation.

I. Leclercq, N. Delzenne, Y. Horsmans, 1998, Journal of hepatology.

Development of hepatic fibrosis occurs normally in AMPK-deficient mice.

B. Viollet, I. Leclercq, A. da Silva Morais, 2010, Clinical science.

Peroxisome proliferated-activated receptor gamma ligand, Pioglitazone, does not prevent hepatic fibrosis in mice.

I. Leclercq, A. da Silva Morais, Y. Horsmans, 2007, International journal of molecular medicine.

Risk of HAART therapy in hepatitis C

I. Leclercq, I. Bica, G. Farrell, 2002, Hepatology.

Nonalcoholic fatty liver disease: the potential role of nutritional management

I. Leclercq, Y. Horsmans, 2008, Current opinion in clinical nutrition and metabolic care.

Percutaneous and surgical radiofrequency ablation of liver malignancies: a single institutional experience.

C. Sempoux, B. V. Van Beers, Y. Horsmans, 2007, Acta gastro-enterologica Belgica.

Yin Yang 1 and farnesoid X receptor: a balancing act in non-alcoholic fatty liver disease?

I. Leclercq, Y. Horsmans, F. Schaap, 2013, Gut.

Glycogenosis storage type I diseases and evolutive adenomatosis: an indication for liver transplantation

O. Ciccarelli, C. Sempoux, J. Lerut, 2002, Transplant international : official journal of the European Society for Organ Transplantation.

Duodenal CD8+ T resident memory cell apoptosis contributes to gut barrier dysfunction and microbial translocation in early alcohol‐associated liver disease in humans

N. Lanthier, I. Leclercq, G. Bommer, 2022, Alimentary pharmacology & therapeutics.

Aging enhances liver fibrotic response in mice through hampering extracellular matrix remodeling

I. Leclercq, P. Henriet, Y. Horsmans, 2016, Aging.

Defective hepatic regeneration after partial hepatectomy in leptin-deficient mice is not rescued by exogenous leptin

C. Sempoux, I. Leclercq, Y. Horsmans, 2006, Laboratory Investigation.

Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE‐induced murine model of chronic liver injury

C. Sempoux, I. Leclercq, Y. Horsmans, 2009, Hepatology.

Can Transient Elastography Replace Liver Histology for Determination of Advanced Fibrosis in Alcoholic Patients: A Real-life Study

P. de Timary, Y. Horsmans, P. Stärkel, 2010, Journal of clinical gastroenterology.

The Liver in COVID-19-Related Death: Protagonist or Innocent Bystander?

M. V. Van Bockstal, Y. Horsmans, P. Baldin, 2020, Pathobiology.

Impact of PPAR-α induction on glucose homoeostasis in alcohol-fed mice.

C. Sempoux, N. Lanthier, I. Leclercq, 2013, Clinical science.

Endoplasmic reticulum stress does not contribute to steatohepatitis in obese and insulin-resistant high-fat-diet-fed foz/foz mice.

C. Sempoux, I. Leclercq, G. Farrell, 2014, Clinical science.

Endoplasmic reticulum stress does not contribute to steatohepatitis in obese and insulin resistant 1 high-fat diet fed foz / foz mice 2 3

C. Sempoux, G. Farrell, Y. Horsmans, 2014 .

Does haemophilia slow down the development of liver fibrosis?

I. Leclercq, C. Hermans, Y. Horsmans, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Cryopreservation of Rat Precision-cut Liver Slices is Associated with Major Metabolic Stress and Ionic Perturbations

F. Bontemps, N. Delzenne, M. Vincent, 2003, Cellular Physiology and Biochemistry.

Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice.

C. Sempoux, I. Leclercq, G. Farrell, 2004, Journal of hepatology.

Limited lamivudine and long-term hepatitis B immunoglobulin immunoprophylaxis for prevention of hepatitis B recurrence after liver transplantation

J. Lerut, Y. Horsmans, P. Starkel, 2002, Transplantation.

Efficacy of lanreotide in preventing the occurrence of chemically induced hepatocellular carcinoma in rats.

C. Sempoux, I. Leclercq, I. Borbath, 2010, Chemico-biological interactions.

Modulatory effect of rapamycin and tacrolimus on monocyte-derived dendritic cells phenotype and function.

F. Conti, N. Delhem, Y. Horsmans, 2020, Immunobiology.

Influence of diet on liver volume and cytochrome P-450 (CYP) activities in human non-alcoholic fatty liver.

I. Leclercq, S. Pauwels, Y. Horsmans, 1996 .

Mucin-producing hepatic cystic neoplasms: an uncommon but challenging disease often misdiagnosed and mismanaged

L. Annet, Y. Horsmans, M. Komuta, 2018, Acta chirurgica Belgica.

Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans

D. Fouts, I. Leclercq, P. de Timary, 2020, Gut microbes.

The oxyhemoglobin dissociation curve in liver cirrhosis.

G. Liistro, T. Clerbaux, A. Frans, 2006, Chest.

Focal nodular hyperplasia: natural course observed with CT and MRI.

C. Sempoux, B. V. Van Beers, J. Jamart, 2000, Journal of computer assisted tomography.

Hepatic haemangioendothelioma in adults: excellent outcome following liver transplantation

O. Ciccarelli, C. Sempoux, B. E. Beers, 2004, Transplant international : official journal of the European Society for Organ Transplantation.

Rare presentation of familial paraganglioma without evidence of mutation in the SDH, RET and VHL genes: towards further genetic heterogeneity

C. Sempoux, B. V. Van Beers, P. Rustin, 2009, Journal of hypertension.

Role of apoptotic signaling pathway in metabolic disturbances occurring in liver tissue after cryopreservation: Study on rat precision-cut liver slices.

A. Neyrinck, N. Delzenne, Y. Horsmans, 2006, Life sciences.

Glycogenosis storage type I diseases and evolutive adenomatosis: an indication for liver transplantation

O. Ciccarelli, C. Sempoux, J. Lerut, 2003 .

Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patients

C. Sempoux, X. Chapaux, I. Borbath, 2010, European journal of gastroenterology & hepatology.

Reactive cholangiocytes differentiate into proliferative hepatocytes with efficient DNA repair in mice with chronic liver injury.

C. Sempoux, B. Bearzatto, Laure-Alix Clerbaux, 2019, Journal of hepatology.

715 EXOGENOUS STEATOSIS AND HEPATIC INSULIN RESISTANCE ARE EARLY CONSEQUENCES OF HIGH FAT FEEDING

N. Lanthier, I. Leclercq, Patrice D Cani, 2009 .

Gadolinium‐enhanced arterial‐phase MR imaging of hypervascular liver tumors: Comparison between tailored and fixed scanning delays in the same patients

R Materne, J Jamart, A M Smith, 2000, Journal of magnetic resonance imaging : JMRI.

Esophageal varices: evaluation with transesophageal MR imaging--initial experience.

B. V. Van Beers, F. Peeters, L. Annet, 2006, Radiology.

Influence of body mass index, sex and age on serum alanine aminotransferase (ALT) level in healthy blood donors.

I. Leclercq, Y. Horsmans, A. Geubel, 1999, Acta gastro-enterologica Belgica.

Influence of sex, age and body mass index on serum alt level in healthy blood donors

I. Leclercq, Y. Horsmans, A. Geubel, 1998 .

Toll-like receptor 2 activation in monocytes contributes to systemic inflammation and alcohol-associated liver disease in humans

G. Laloux, I. Leclercq, S. Leclercq, 2023, Hepatology communications.

AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults.

P. Pickhardt, I. Leclercq, Y. Horsmans, 2023, Radiology.

Comparison of MR elastography, ultrasound elastography and apri for the non-invasive assessment of liver fibrosis

C. Sempoux, L. Huwart, L. Annet, 2007 .

Inhibition of early preneoplastic events in the rat liver by the somatostatin analog lanreotide

C. Sempoux, I. Leclercq, I. Borbath, 2007, Cancer science.

Prognostic risk factors of survival after resection of hepatocellular carcinoma.

C. Sempoux, B. V. Van Beers, L. Annet, 2007, Hepato-Gastroenterology.

Occult HBV reactivation induced by ibrutinib treatment: a case report.

C. Sempoux, N. Lanthier, Y. Horsmans, 2015, Acta gastro-enterologica Belgica.

The Ras inhibitor farnesylthiosalicyclic acid (FTS) prevents nodule formation and development of preneoplastic foci of altered hepatocytes in rats.

I. Leclercq, T. Schneider-Merck, I. Borbath, 2009, European journal of cancer.

Endoscopic Resection of Superficial Gastric Tumors

Y. Horsmans, P. Deprez, H. Piessevaux, 2007 .

Endoscopic Resection of Upper GI Superficial Tumors: Complications, Management and Outcome

Y. Horsmans, P. Deprez, H. Piessevaux, 2007 .

After portal branch ligation in the rat, cellular proliferation in associated with selective induction of c-Ha-ras, p53, cyclin E, and Cdk2

C. Sempoux, A. Saliez, Y. Horsmans, 2001, Gut.

Severe radiation‐induced liver disease following localized radiation therapy for biliopancreatic carcinoma: Activation of hepatic stellate cells as an early event

C. Sempoux, B. V. Van Beers, Y. Horsmans, 1997, Hepatology.

Cytochrome P450 3A proteins are expressed in B lymphocytes but not in T lymphocytes.

C. Sempoux, Y. Horsmans, Y. Horsmans, 1999, Pharmacogenetics.

Liver ﬁbrosis: non-invasive assessment with MR elastography

R. Sinkus, B. E. Beers, L. Huwart, 2022 .

Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study

N. Delzenne, Y. Horsmans, Y. Horsmans, 2005, European Journal of Clinical Nutrition.

Cell Biology of NASH: Fibrosis and cell proliferation

I. Leclercq, Y. Horsmans, 2005 .

Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE‐induced murine model of chronic liver injury

C. Sempoux, I. Leclercq, Y. Horsmans, 2009, Hepatology.

Impact of PPAR-α induction on glucose homoeostasis in alcohol-fed mice.

C. Sempoux, N. Lanthier, I. Leclercq, 2013, Clinical science.

Alcohol-associated bowel disease: new insights into pathogenesis

I. Leclercq, Y. Horsmans, G. Kunos, 2023, eGastroenterology.

Dynamic computed tomography with low- and high-molecular-mass contrast agents to assess microvascular permeability modifications in a model of liver fibrosis.

S. Dechambre, C. Sempoux, B. V. Van Beers, 2002, Clinical science.

Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats

C. Sempoux, I. Leclercq, Y. Horsmans, 2006, Gut.

Adult liver transplantation at UCL: update 2002.

O. Ciccarelli, C. Sempoux, D. Latinne, 2004, Acta gastro-enterologica Belgica.

Cryopreservation of rat precision-cut liver slices by ultrarapid freezing: influence on phase I and II metabolism and on cell viability upon incubation for 24 hours.

P. Calderon, N. Delzenne, Y. Horsmans, 2001, Life sciences.

The PPARgamma agonist pioglitazone inhibits early neoplastic occurrence in the rat liver.

C. Sempoux, I. Leclercq, I. Borbath, 2007, European journal of cancer.